Global Institute for Hispanic Health

The Global Institute for Hispanic Health (GIHH) is a clinical research organization and site dedicated to increasing the representation of Hispanic and Latino populations in medical research. Based in San Antonio, Texas, the institute specializes in conducting Phase 1 through Phase 4 clinical trials with a particular focus on conditions that disproportionately affect the Hispanic community, such as liver disease and metabolic disorders. GIHH partners with major pharmaceutical companies and healthcare providers to provide culturally competent research environments and community outreach. By bridging the gap in clinical trial diversity, the organization ensures that emerging therapies are evaluated for safety and efficacy across diverse genetic and cultural backgrounds.